Prognostic impact of Chagas' disease in patients awaiting heart transplantation. 2010

Natália D Bertolino, and Daniel F Villafanha, and Augusto Cardinalli-Neto, and José A Cordeiro, and Milena J Arcanjo, and Tatiana A D Theodoropoulos, and Reinaldo B Bestetti
Hospital de Base, São José do Rio Preto city, Brazil.

BACKGROUND The role of Chagas' etiology of chronic heart failure in predicting patient outcomes while awaiting heart transplantation is unknown. Accordingly, in this study we compare outcomes in Chagas' disease with non-Chagas'-disease-related advanced heart failure among patients on the waiting list for heart transplantation. METHODS We reviewed the clinical outcomes of 103 consecutive patients with chronic heart failure listed for heart transplantation from August 2000 to January 2008 at a single institution. Forty-six (44%) patients were diagnosed with Chagas' disease on the basis of positive serology. A Cox proportional hazards model was used to establish independent predictors of mortality, whereas competing risk analysis was used to estimate time-related prevalence of death and heart transplantation in Chagas' disease and non-Chagas' disease patients. RESULTS In the multivariate model, inotropic support (p < 0.0005; hazard ratio = 5.96; 95% confidence interval [CI] 2.41 to 14.71) and Chagas' disease etiology of heart failure (p = 0.02; hazard ratio = 2.27; 95% CI 1.14 to 4.52) were retained as independent predictors of mortality. Prevalence of death at 100 days after listing was 30% in Chagas' disease and 16% in non-Chagas' disease patients (p = 0.02), despite no difference in the competing rates of transplantation (30% in Chagas' and 37% in non-Chagas' patients, p = 0.5). CONCLUSIONS Chagas' disease etiology serves as an independent predictor of mortality in patients listed for heart transplantation, with a worse outcome when compared with non-Chagas' disease patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D014355 Chagas Disease Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON. Trypanosomiasis, South American,American Trypanosomiasis,Chagas' Disease,Trypanosoma cruzi Infection,Infection, Trypanosoma cruzi,Infections, Trypanosoma cruzi,South American Trypanosomiasis,Trypanosoma cruzi Infections,Trypanosomiasis, American

Related Publications

Natália D Bertolino, and Daniel F Villafanha, and Augusto Cardinalli-Neto, and José A Cordeiro, and Milena J Arcanjo, and Tatiana A D Theodoropoulos, and Reinaldo B Bestetti
November 1992, Pacing and clinical electrophysiology : PACE,
Natália D Bertolino, and Daniel F Villafanha, and Augusto Cardinalli-Neto, and José A Cordeiro, and Milena J Arcanjo, and Tatiana A D Theodoropoulos, and Reinaldo B Bestetti
September 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
Natália D Bertolino, and Daniel F Villafanha, and Augusto Cardinalli-Neto, and José A Cordeiro, and Milena J Arcanjo, and Tatiana A D Theodoropoulos, and Reinaldo B Bestetti
May 1996, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
Natália D Bertolino, and Daniel F Villafanha, and Augusto Cardinalli-Neto, and José A Cordeiro, and Milena J Arcanjo, and Tatiana A D Theodoropoulos, and Reinaldo B Bestetti
January 1987, The Journal of heart transplantation,
Natália D Bertolino, and Daniel F Villafanha, and Augusto Cardinalli-Neto, and José A Cordeiro, and Milena J Arcanjo, and Tatiana A D Theodoropoulos, and Reinaldo B Bestetti
January 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
Natália D Bertolino, and Daniel F Villafanha, and Augusto Cardinalli-Neto, and José A Cordeiro, and Milena J Arcanjo, and Tatiana A D Theodoropoulos, and Reinaldo B Bestetti
February 2010, The Thoracic and cardiovascular surgeon,
Natália D Bertolino, and Daniel F Villafanha, and Augusto Cardinalli-Neto, and José A Cordeiro, and Milena J Arcanjo, and Tatiana A D Theodoropoulos, and Reinaldo B Bestetti
October 2023, ESC heart failure,
Natália D Bertolino, and Daniel F Villafanha, and Augusto Cardinalli-Neto, and José A Cordeiro, and Milena J Arcanjo, and Tatiana A D Theodoropoulos, and Reinaldo B Bestetti
November 1998, Journal of psychosomatic research,
Natália D Bertolino, and Daniel F Villafanha, and Augusto Cardinalli-Neto, and José A Cordeiro, and Milena J Arcanjo, and Tatiana A D Theodoropoulos, and Reinaldo B Bestetti
March 2004, Critical care medicine,
Natália D Bertolino, and Daniel F Villafanha, and Augusto Cardinalli-Neto, and José A Cordeiro, and Milena J Arcanjo, and Tatiana A D Theodoropoulos, and Reinaldo B Bestetti
September 1996, Giornale italiano di cardiologia,
Copied contents to your clipboard!